[Screening for Fragile X syndrome mutations during early pregnancy--results and mothers' opinions about the gene test].
Ryynänen
M
M
KYS:n naistentautien ja synnytysklinikka 70211 Kuopio. markku.ryynanen@kuh.fi
Heinonen
S
S
Makkonen
M
M
Mannermaa
A
A
Kirkinen
P
P
D004252:DNA Mutational Analysis; D005260:Female; D005387:Finland / Q000453:epidemiology; D051860:Fragile X Messenger Ribonucleoprotein 1; D005600:Fragile X Syndrome / Q000175:diagnosis* / Q000453:epidemiology / Q000235:genetics; D005820:Genetic Testing; D006801:Humans; D009035:Mothers / Q000523:psychology*; D009154:Mutation; D009419:Nerve Tissue Proteins / Q000235:genetics; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011262:Pregnancy Trimester, Second; D016601:RNA-Binding Proteins; D019680:Trinucleotide Repeat Expansion
D051860:Fragile X Messenger Ribonucleoprotein 1; D009419:Nerve Tissue Proteins; D016601:RNA-Binding Proteins; C497683:FMR1 protein, human